TCTMD

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Patients who have residual dissection after being treated with second-generation drug-coated balloons (DCBs) in native coronary lesions still have acceptable outcomes, according to observational data ...
TCTMD

TCT 1823: Drug-Coated Balloon Treatment Despite an Angiographic Dissection to Avoid Dual Antiplatelet Therapy in a Patient Needing Vascular Surgery in Short Time

TCT 1824: Going Beyond Metal: The Treatment of a Highly Calcified Long LAD Lesion With Rotatripsy and Sirolimus-Coated Balloon in a Patient With Low Ejection Fraction and High-Bleeding Risk Receive ...
National Institute for Health and Care Excellence

Endoaortic balloon occlusion for cardiac surgery

Endoaortic balloon occlusion is performed to achieve temporary obstruction of the aorta during cardiac surgery, including mitral valve repair or replacement and coronary artery bypass grafting.
Financial Post

Philips announces positive three-year clinical research results from its Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the latest results from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial ...